{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T15:44:53Z","timestamp":1793547893319,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T00:00:00Z","timestamp":1622246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T00:00:00Z","timestamp":1622246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100014509","name":"Winnipeg Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014509","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008795","name":"Manitoba Medical Services Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008795","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The prevalence of epilepsy in pregnant women is estimated at 0.3-1%. Anti-epileptic drug (AED) exposure in-utero has been associated with various adverse health outcomes in neonates, including adverse birth weight outcomes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>This review aims to summarize the published evidence on the association between AED exposure in pregnancy and adverse birth weight outcomes<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Studies assessing AED exposure in pregnancy and neonatal birth weight outcomes, including small for gestational age (SGA), low birth weight (LBW), birth weight (BW), length, head circumference, and cephalization index will be identified in MEDLINE\u00ae, EMBASE, Cochrane Library, Scopus, Cumulative Index of Nursing and Allied Health Literature (CINAHL), International Pharmaceutical Abstracts (IPA), and Global Health. Open grey, Theses Canada, and ProQuest Dissertations will be used to locate gray literature. Eligible study designs will include both intervention and non-interventional studies. We will not impose any time limit in the review. We will use the Newcastle-Ottawa Scale to assess the methodological quality of observational studies and quasi-experimental studies included in the review. The risk of bias of experimental studies will be appraised using the Cochrane risk-of-bias tool for randomized trials (RoB 2). A meta-analysis will be conducted using a random-effects model.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>The results from this review could improve clinicians\u2019 prescribing decisions by highlighting the safest AEDs for women who are pregnant or planning to conceive based on the evidence currently available.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Systematic review registration<\/jats:title>\n                <jats:p>PROSPERO CRD42020192713<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13643-021-01711-8","type":"journal-article","created":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T04:07:48Z","timestamp":1622261268000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Anti-epileptic drug exposure during pregnancy and neonatal birth weight outcomes: protocol for a systematic review and meta-analysis"],"prefix":"10.1186","volume":"10","author":[{"given":"Alekhya","family":"Lavu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Vaccaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walid","family":"Shouman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Alessi","family":"Severini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0520-5406","authenticated-orcid":false,"given":"Sherif","family":"Eltonsy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,29]]},"reference":[{"key":"1711_CR1","doi-asserted-by":"crossref","unstructured":"WHO. Atlas: epilepsy care in the world.; 2005. doi:10.1017\/CBO9781107415324.004","DOI":"10.1017\/CBO9781107415324.004"},{"issue":"13","key":"1711_CR2","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1111\/j.1471-0528.2009.02354.x","volume":"116","author":"I Borthen","year":"2009","unstructured":"Borthen I, Eide MG, Veiby G, Daltveit AK, Gilhus NE. Complications during pregnancy in women with epilepsy: population-based cohort study. BJOG An Int J Obstet Gynaecol. 2009;116(13):1736\u201342. https:\/\/doi.org\/10.1111\/j.1471-0528.2009.02354.x.","journal-title":"BJOG An Int J Obstet Gynaecol."},{"issue":"1","key":"1711_CR3","first-page":"e89","volume":"18","author":"K Brosh","year":"2011","unstructured":"Brosh K, Matok I, Sheine E, et al. Teratogenic determinants of first- trimester exposure to anti-epileptic medications. J Popul Ther Clin Pharmacol. 2011;18(1):e89\u201398 pmid: 21467600.","journal-title":"J Popul Ther Clin Pharmacol"},{"issue":"4","key":"1711_CR4","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.yebeh.2012.05.010","volume":"24","author":"PB Pennell","year":"2012","unstructured":"Pennell PB, Klein AM, Browning N, Baker GA, Clayton-Smith J, Kalayjian LA, et al. Differential effects of anti-epileptic drugs on neonatal outcomes. Epilepsy Behav. 2012;24(4):449\u201356. https:\/\/doi.org\/10.1016\/j.yebeh.2012.05.010.","journal-title":"Epilepsy Behav."},{"issue":"11","key":"1711_CR5","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1111\/epi.12758","volume":"55","author":"D Kilic","year":"2014","unstructured":"Kilic D, Pedersen H, Kjaersgaard MIS, et al. Birth outcomes after prenatal exposure to anti-epileptic drugs - a population-based study. Epilepsia. 2014;55(11):1714\u201321. https:\/\/doi.org\/10.1111\/epi.12758.","journal-title":"Epilepsia"},{"issue":"2","key":"1711_CR6","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1212\/WNL.0b013e3181a6b312","volume":"73","author":"CL Harden","year":"2009","unstructured":"Harden CL, Meador KJ, Pennell PB, et al. Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee. Neurology. 2009;73(2):133\u201341. https:\/\/doi.org\/10.1212\/WNL.0b013e3181a6b312.","journal-title":"Neurology"},{"issue":"8","key":"1711_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0214180","volume":"14","author":"A.V. M, A.S. O, Margulis A V., et a","year":"2019","unstructured":"A.V. M, A.S. O, Margulis A V., et al. Relation of in-utero exposure to anti-epileptic drugs to pregnancy duration and size at birth. PLoS One. 2019;14(8):1\u201321. https:\/\/doi.org\/10.1371\/journal.pone.0214180.","journal-title":"PLoS One."},{"issue":"8","key":"1711_CR8","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1001\/jamaneurol.2017.1310","volume":"74","author":"N Razaz","year":"2017","unstructured":"Razaz N, Tomson T, Wikstr\u00f6m A-KK, Cnattingius S. Association between pregnancy and perinatal outcomes among women with epilepsy. JAMA Neurol. 2017;74(8):983\u201391. https:\/\/doi.org\/10.1001\/jamaneurol.2017.1310.","journal-title":"JAMA Neurol."},{"issue":"3","key":"1711_CR9","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/ana.25031","volume":"82","author":"S Hern\u00e1ndez-D\u00edaz","year":"2017","unstructured":"Hern\u00e1ndez-D\u00edaz S, McElrath TF, Pennell PB, Hauser WA, Yerby M, Holmes LB. Fetal growth and premature delivery in pregnant women on anti-epileptic drugs. Ann Neurol. 2017;82(3):457\u201365. https:\/\/doi.org\/10.1002\/ana.25031.","journal-title":"Ann Neurol."},{"issue":"3","key":"1711_CR10","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1067\/mob.2001.116749","volume":"185","author":"BA Doctor","year":"2001","unstructured":"Doctor BA, O\u2019Riordan MA, Kirchner HL, Shah D, Hack M. Perinatal correlates and neonatal outcomes of small for gestational age infants born at term gestation. Am J Obstet Gynecol. 2001;185(3):652\u20139. https:\/\/doi.org\/10.1067\/mob.2001.116749.","journal-title":"Am J Obstet Gynecol."},{"issue":"3","key":"1711_CR11","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.beem.2008.01.014","volume":"22","author":"EM Lundgren","year":"2008","unstructured":"Lundgren EM, Tuvemo T. Effects of being born small for gestational age on long-term intellectual performance. Best Pract Res Clin Endocrinol Metab. 2008;22(3):477\u201388. https:\/\/doi.org\/10.1016\/j.beem.2008.01.014.","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"key":"1711_CR12","unstructured":"de la Calzada DG, Garc\u00eda LO, Rem\u00edrez JM, L\u00e1zaro A, Cajal MD. Study of early detection of cardiovascular risk factors in children born small (SGA) and review of literature. Pediatr Endocrinol Rev. 6(Suppl 3):343\u20139 http:\/\/europepmc.org\/abstract\/MED\/19404233."},{"issue":"27","key":"1711_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MD.0000000000000210","volume":"93","author":"J Liu","year":"2014","unstructured":"Liu J, Wang XF, Wang Y, Wang HW, Liu Y. The incidence rate, high-risk factors, and short- and long-term adverse outcomes of fetal growth restriction. Med (United States). 2014;93(27):1\u20135. https:\/\/doi.org\/10.1097\/MD.0000000000000210.","journal-title":"Med (United States)."},{"issue":"2","key":"1711_CR14","doi-asserted-by":"publisher","first-page":"130.e1","DOI":"10.1016\/j.ajog.2012.11.014","volume":"208","author":"AK Von Beckerath","year":"2013","unstructured":"Von Beckerath AK, Kollmann M, Rotky-Fast C, Karpf E, Lang U, Klaritsch P. Perinatal complications and long-term neurodevelopmental outcome of infants with intrauterine growth restriction. Am J Obstet Gynecol. 2013;208(2):130.e1\u20136. https:\/\/doi.org\/10.1016\/j.ajog.2012.11.014.","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"1711_CR15","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/S0306-5456(00)00205-9","volume":"108","author":"B Clausson","year":"2001","unstructured":"Clausson B, Gardosi J, Francis A, Cnattingius S. Perinatal outcome in SGA births defined by customised versus population-based birthweight standards. Br J Obstet Gynaecol. 2001;108(8):830\u20134. https:\/\/doi.org\/10.1016\/S0306-5456(00)00205-9.","journal-title":"Br J Obstet Gynaecol."},{"issue":"12","key":"1711_CR16","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1007\/s00125-010-1917-3","volume":"53","author":"K Pilgaard","year":"2010","unstructured":"Pilgaard K, F\u00e6rch K, Carstensen B, Poulsen P, Pisinger C, Pedersen O, et al. Low birthweight and premature birth are both associated with type 2 diabetes in a random sample of middle-aged Danes. Diabetologia. 2010;53(12):2526\u201330. https:\/\/doi.org\/10.1007\/s00125-010-1917-3.","journal-title":"Diabetologia."},{"issue":"1","key":"1711_CR17","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12916-017-0845-1","volume":"15","author":"AA Veroniki","year":"2017","unstructured":"Veroniki AA, Cogo E, Rios P, Straus SE, Finkelstein Y, Kealey R, et al. Comparative safety of anti-epileptic drugs during pregnancy: a systematic review and network meta-analysis of congenital malformations and prenatal outcomes. BMC Med. 2017;15(1):95. https:\/\/doi.org\/10.1186\/s12916-017-0845-1.","journal-title":"BMC Med."},{"issue":"Suppl 2","key":"1711_CR18","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1007\/s40263-017-0433-0","volume":"26","author":"AV Margulis","year":"2017","unstructured":"Margulis AV, Oberg AS, Hernandez-Diaz S. Anti-epileptic drugs in pregnancy: searching for a reference drug for comparative safety. Pharmacoepidemiol Drug Safety. 2017;26(Suppl 2):408. https:\/\/doi.org\/10.1007\/s40263-017-0433-0.","journal-title":"Pharmacoepidemiol Drug Safety"},{"issue":"10","key":"1711_CR19","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.seizure.2010.10.027","volume":"19","author":"MJ Brodie","year":"2010","unstructured":"Brodie MJ. Anti-epileptic drug therapy the story so far. Seizure. 2010;19(10):650\u20135. https:\/\/doi.org\/10.1016\/j.seizure.2010.10.027.","journal-title":"Seizure."},{"issue":"7785","key":"1711_CR20","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1136\/bmj.c6581","volume":"341","author":"J Jentink","year":"2010","unstructured":"Jentink J, Dolk H, Loane MA, Morris JK, Wellesley D, Garne E, et al. Intrauterine exposure to carbamazepine and specific congenital malformations: systematic review and case-control study. BMJ. 2010;341(7785):1261. https:\/\/doi.org\/10.1136\/bmj.c6581.","journal-title":"BMJ."},{"issue":"7","key":"1711_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjopen-2017-017248","volume":"7","author":"AA Veroniki","year":"2017","unstructured":"Veroniki AA, Rios P, Cogo E, Straus SE, Finkelstein Y, Kealey R, et al. Comparative safety of anti-epileptic drugs for neurological development in children exposed during pregnancy and breast feeding: a systematic review and network meta-analysis. BMJ Open. 2017;7(7):1\u201311. https:\/\/doi.org\/10.1136\/bmjopen-2017-017248.","journal-title":"BMJ Open."},{"issue":"10006","key":"1711_CR22","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1016\/S0140-6736(15)00045-8","volume":"386","author":"L Viale","year":"2015","unstructured":"Viale L, Allotey J, Cheong-See F, Arroyo-Manzano D, Mccorry D, Bagary M, et al. Epilepsy in pregnancy and reproductive outcomes: a systematic review and meta-analysis. Lancet. 2015;386(10006):1845\u201352. https:\/\/doi.org\/10.1016\/S0140-6736(15)00045-8.","journal-title":"Lancet."},{"issue":"3","key":"1711_CR23","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s00404-017-4404-y","volume":"296","author":"D Chen","year":"2017","unstructured":"Chen D, Hou L, Duan X, Peng H, Peng B. Effect of epilepsy in pregnancy on fetal growth restriction: a systematic review and meta-analysis. Arch Gynecol Obstet. 2017;296(3):421\u20137. https:\/\/doi.org\/10.1007\/s00404-017-4404-y.","journal-title":"Arch Gynecol Obstet."},{"issue":"6","key":"1711_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40263-017-0433-0","volume":"31","author":"G Pariente","year":"2017","unstructured":"Pariente G, Leibson T, Shulman T, Adams-Webber T, Barzilay E, Nulman I. Pregnancy outcomes following in utero exposure to lamotrigine: a systematic review and meta-analysis. CNS Drugs. 2017;31(6):1\u201312. https:\/\/doi.org\/10.1007\/s40263-017-0433-0.","journal-title":"CNS Drugs."},{"issue":"48","key":"1711_CR25","doi-asserted-by":"publisher","first-page":"6518","DOI":"10.1016\/j.vaccine.2017.01.040","volume":"35","author":"EP Schlaudecker","year":"2017","unstructured":"Schlaudecker EP, Munoz FM, Bardaj\u00ed A, Boghossian NS, Khalil A, Mousa H, et al. Small for gestational age: case definition & guidelines for data collection, analysis, and presentation of maternal immunisation safety data. Vaccine. 2017;35(48):6518\u201328. https:\/\/doi.org\/10.1016\/j.vaccine.2017.01.040.","journal-title":"Vaccine."},{"issue":"2","key":"1711_CR26","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1093\/oxfordjournals.epirev.a018039","volume":"22","author":"CL Hvas","year":"2000","unstructured":"Hvas CL, Henriksen TB, \u00d8stergaard JR. Birth weight in offspring of women with epilepsy. Epidemiol Rev. 2000;22(2):275\u201382. https:\/\/doi.org\/10.1093\/oxfordjournals.epirev.a018039.","journal-title":"Epidemiol Rev."},{"key":"1711_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmj.g7647","volume":"Vol 349","author":"L Shamseer","year":"2015","unstructured":"Shamseer L, Moher D, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ (Online). 2015;Vol 349:1\u201325. https:\/\/doi.org\/10.1136\/bmj.g7647.","journal-title":"BMJ (Online)"},{"key":"1711_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/5515831","volume":"2021","author":"V Yadav","year":"2021","unstructured":"Yadav V, Dabar D, Goel AD, Bairwa M, Sood A, Prasad P, et al. Prevalence of hypothyroidism in pregnant women in India: a meta-analysis of observational studies. J Thyroid Res. 2021;2021:1\u201319. https:\/\/doi.org\/10.1155\/2021\/5515831.","journal-title":"J Thyroid Res."},{"issue":"1","key":"1711_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):1\u201310. https:\/\/doi.org\/10.1186\/s13643-016-0384-4.","journal-title":"Syst Rev."},{"key":"1711_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:1\u20138. https:\/\/doi.org\/10.1136\/bmj.l4898.","journal-title":"BMJ."},{"issue":"3","key":"1711_CR31","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1111\/biom.12817","volume":"74","author":"L Lin","year":"2018","unstructured":"Lin L, Chu H. Quantifying publication bias in meta-analysis. Biometrics. 2018;74(3):785\u201394. https:\/\/doi.org\/10.1111\/biom.12817.","journal-title":"Biometrics."},{"issue":"11","key":"1711_CR32","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1503\/cmaj.1031981","volume":"171","author":"T McGinn","year":"2004","unstructured":"McGinn T, Wyer PC, Newman TB, Keitz S, Leipzig R, Guyatt G. Tips for learners of evidence-based medicine: 3. Measures of observer variability (kappa statistic). Cmaj. 2004;171(11):1369\u201373. https:\/\/doi.org\/10.1503\/cmaj.1031981.","journal-title":"Cmaj."},{"key":"1711_CR33","doi-asserted-by":"publisher","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ WV (editors). Cochrane handbook for systematic reviews of interventions version 6.2.; 2021. doi:doi:https:\/\/doi.org\/10.1002\/9781119536604.ch10","DOI":"10.1002\/9781119536604.ch10"},{"issue":"2","key":"1711_CR34","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1177\/1536867x0400400204","volume":"4","author":"JAC Sterne","year":"2004","unstructured":"Sterne JAC, Harbord RM. Funnel plots in meta-analysis. Stata J Promot Commun Stat Stata. 2004;4(2):127\u201341. https:\/\/doi.org\/10.1177\/1536867x0400400204.","journal-title":"Stata J Promot Commun Stat Stata."},{"issue":"1","key":"1711_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12884-015-0663-4","volume":"15","author":"E Oulman","year":"2015","unstructured":"Oulman E, Kim THM, Yunis K, Tamim H. Prevalence and predictors of unintended pregnancy among women: an analysis of the Canadian Maternity Experiences Survey. BMC Pregnancy Childbirth. 2015;15(1):1\u20138. https:\/\/doi.org\/10.1186\/s12884-015-0663-4.","journal-title":"BMC Pregnancy Childbirth."},{"issue":"2","key":"1711_CR36","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1177\/039463200301600213","volume":"16","author":"SH Huang","year":"2003","unstructured":"Huang SH, Gambi FI, Conti FI, Carratelli G, Conti CMV, Mastromauro I, et al. Letter to the Editor Antiepileptic drugs lower contraceptive sex hormone and increase the risk of unplanned pregnancies in women with epilepsy: revisited study. Int J Immunopathol Pharmacol. 2003;16(2):181\u20133. https:\/\/doi.org\/10.1177\/039463200301600213.","journal-title":"Int J Immunopathol Pharmacol."},{"issue":"4","key":"1711_CR37","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s40262-019-00845-2","volume":"0123456789","author":"IJ Arfman","year":"2020","unstructured":"Arfman IJ. Wammes-van der Heijden EA, ter Horst PGJ, Lambrechts DA, Wegner I, Touw DJ. Therapeutic drug monitoring of antiepileptic drugs in women with epilepsy before, during, and after pregnancy. Clin Pharmacokinet. 2020;0123456789(4):427\u201345. https:\/\/doi.org\/10.1007\/s40262-019-00845-2.","journal-title":"Clin Pharmacokinet."}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-021-01711-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13643-021-01711-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-021-01711-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T04:08:12Z","timestamp":1622261292000},"score":1,"resource":{"primary":{"URL":"https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-021-01711-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,29]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1711"],"URL":"https:\/\/doi.org\/10.1186\/s13643-021-01711-8","relation":{},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,29]]},"assertion":[{"value":"7 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"159"}}